Hepatocytes execute the metabolic activities of the liver and show functional heterogeneity along the axis within the lobule defined from the portal vein to the central vein 12 . At the extreme ends of this axis, pericentral AXIN2
. In adults, new hepatocytes originate from the existing hepatocyte pool [3] [4] [5] [6] [7] [8] , but the cellular source of renewing hepatocytes remains unclear. Telomerase is expressed in many stem cell populations, and mutations in telomerase pathway genes have been linked to liver diseases [9] [10] [11] . Here we identify a subset of hepatocytes that expresses high levels of telomerase and show that this hepatocyte subset repopulates the liver during homeostasis and injury. Using lineage tracing from the telomerase reverse transcriptase (Tert) locus in mice, we demonstrate that rare hepatocytes with high telomerase expression (TERT High hepatocytes) are distributed throughout the liver lobule. During homeostasis, these cells regenerate hepatocytes in all lobular zones, and both self-renew and differentiate to yield expanding hepatocyte clones that eventually dominate the liver. In response to injury, the repopulating activity of TERT High hepatocytes is accelerated and their progeny cross zonal boundaries. RNA sequencing shows that metabolic genes are downregulated in TERT High hepatocytes, indicating that metabolic activity and repopulating activity may be segregated within the hepatocyte lineage. Genetic ablation of TERT High hepatocytes combined with chemical injury causes a marked increase in stellate cell activation and fibrosis. These results provide support for a 'distributed model' of hepatocyte renewal in which a subset of hepatocytes dispersed throughout the lobule clonally expands to maintain liver mass.
Hepatocytes execute the metabolic activities of the liver and show functional heterogeneity along the axis within the lobule defined from the portal vein to the central vein 12 . At the extreme ends of this axis, pericentral AXIN2
+ hepatocytes repopulate the liver during normal homeostasis 13 , whereas periportal hepatocytes marked by SOX9 expression are inactive during homeostasis but expand in response to chronic chemical damage 14 . Observations indicating that proliferating hepatocytes are located throughout the lobule 15, 16 suggest that additional sources of repopulating hepatocytes exist. Telomerase synthesizes telomere repeats and has been linked to long-term renewal in stem cells and cancers 17 . Germline inactivating mutations in telomerase genes predispose humans and mice to cirrhosis [9] [10] [11] , while activating mutations in the TERT promoter represent the most recurrent mutations in hepatocellular carcinoma 18 . Given the important roles of telomerase in liver disease, and observations that telomerase is found in stem cell compartments in multiple adult tissues [19] [20] [21] [22] , we hypothesized that telomerase may be expressed in liver cells with unique properties.
To identify telomerase-expressing cells in vivo, we engineered a mouse strain expressing the inducible CreER T2 recombinase from the endogenous Tert locus (Extended Data Fig. 1a- 
d). Treatment of Tert
CreERT2/+ knock-in mouse embryonic stem (ES) cells in culture with 4-hydroxy tamoxifen resulted in efficient recombination of a fluorescent reporter (Extended Data Fig. 1e-g ). To study the adult liver, we crossed Tert CreERT2/+ mice with a Rosa26 LSL-Tomato/+ reporter strain that enables permanent cell labelling by deletion of a transcriptional stop element flanked by loxP sites and concomitant expression of fluorescent Tomato protein.
Tert
CreERT2/+ Rosa26 LSL-Tomato/+ mice were injected with a near-saturating dose of tamoxifen (1 mg per 10 g body weight; Extended Data Fig. 1i ), and analysed 3 days later (Fig. 1a) . We found that a subset of cells throughout the liver expressed Tomato and the hepatocyte marker HNF4A (Fig. 1b) . Tomato expression was not detected in other liver cell types (Extended Data Fig. 1k-n) . To isolate these TERT High hepatocytes by fluorescence-activated cell sorting (FACS) (see Supplementary Information), we labelled all hepatocytes with an adeno-associated virus expressing hepatocyte-specific GFP (AAV-GFP) 23 ( Fig. 1c and Extended Data Fig. 1h ). We found that all 
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Tomato + cells were also GFP + , typically representing 3-5% of all hepatocytes from 2-month-old mice (Fig. 1d) Supplementary Fig. 1 ). Quantitative reverse transcription PCR (RT-qPCR) showed that there was 12.9-fold more Tert mRNA in the TERT High population than in the bulk TERT Low hepatocyte population (Fig. 1f, g ). Both populations comprised a similar distribution of diploid and polyploid cells (Extended Data Fig. 2 ). These data show that Tert mRNA and telomerase activity are elevated in TERT High hepatocytes. To determine whether TERT High hepatocytes repopulate the liver during homeostasis, we performed lineage tracing by injecting twomonth old Tert CreERT2/+ Rosa26 LSL-Tomato/+ mice with a single dose of tamoxifen (1 mg per 10 g body weight) or oil vehicle and allowed these animals to age for up to 1 year (Fig. 2a) . TERT High hepatocytes represented 2.8 ± 0.4% of liver area 3 days after tamoxifen treatment, but the Tomato + progeny of these cells increased progressively during the tracing period to comprise 29.9 ± 2.4% of liver area at 1 year (Fig. 2b-h ). All Tomato + cells detected after 1 year were HNF4A + hepatocytes (Extended Data Fig. 3a-e) , and Tomato + cells were not detected in mice treated with oil vehicle (Fig. 2i) . A single tamoxifen injection generated a similar number of Tomato + hepatocytes as three injections administered at 5-week intervals over the same tracing period (Extended Data Fig. 3f-i) , indicating that elevated Tert promoter activity is an intrinsic feature of cell identity. Co-staining of sections from this lineage tracing time course series for Tomato and the pericentral zone marker glutamine synthetase (GS) 12 showed that TERT High hepatocytes were distributed throughout all lobular zones. The vast majority of TERT High hepatocytes were located in the periportal and midlobular zones (3-day trace), and the progeny from these cells expanded markedly to replenish hepatocytes in these zones. Within the pericentral zone, the TERT High lineage comprised 1.8 ± 0.3% of cells at 3 days (Fig. 2j) , but increased over time (8.2 ± 0.5% at 6 months and 12.7 ± 0.9% at 1 year; Fig. 2k -m and Extended Data Fig. 4) . Analysis of proliferating hepatocyte position by Ki-67 immunostaining revealed that Ki-67 + hepatocytes were dispersed throughout all lobular zones in both wild-type and Tert CreERT2/+ mice, matching the distributed pattern of TERT High hepatocytes (Extended Data Fig. 5a , b, h). These data show that rare TERT High hepatocytes drive a marked and progressive repopulation of the hepatocyte lineage throughout the lobule during normal homeostasis.
To understand how TERT High cells differ from bulk hepatocytes, we performed RNA sequencing (RNA-seq) on TERT High Fig. 3j) showed that cell cycle genes were upregulated in the TERT High population, whereas ribosomal genes and mitochondrial genes were upregulated in the TERT Low population. Gene set enrichment analysis (GSEA) revealed increased representation of gene sets associated with cell division and receptor tyrosine kinase activity in the TERT High population (Fig. 2o, red) , and decreased representation of gene sets associated with ribosome components, mitochondrial proteins, the electron transport chain and hepatocyte metabolic activities (Fig. 2o, grey) . Proliferation in TERT High hepatocytes was higher than in TERT Low hepatocytes (6.4 ± 1.0% versus 0.9 ± 0.1%) by 5-ethynyl-2′-deoxyuridine (EdU) incorporation (for 7 days in drinking water, Extended Data Fig. 6 ). Together, these data suggest that TERT High hepatocytes are less invested in the metabolic and synthetic functions of bulk hepatocytes, and more dedicated to proliferation and homeostatic renewal, than TERT Low hepatocytes. To characterize the behaviour of single TERT High hepatocytes and their progeny through clonal analysis and sparse labelling, we injected
Tert
CreERT2/+ Rosa26 LSL-Tomato/+ mice with a lower dose of tamoxifen (0.08 mg per 10 g body weight), and performed lineage tracing for 3 days, 3 months or 6 months (Fig. 3a) . Confocal microscopy was performed on thick tissue sections and followed by three-dimensional reconstruction (Fig. 3b) . The average clone size increased progressively from single cells at 3 days to 2.1 ± 0.2 cells at 3 months and 4.2 ± 0.4 cells at 6 months (Fig. 3c) . Average clonal density did not change, indicating that there was no significant loss of TERT High hepatocyte clones over the 6-month trace (Fig. 3d) . The irregular shape of these clones matches the anatomical organization of hepatocytes within hepatic cords 24 . Co-staining of 6-month trace samples with antibodies against GS revealed that the vast majority of clones resided outside the GS + zone (Fig. 3e , h (red bars)), and a subset of these bordered the GS + pericentral zone (Fig. 3f, h (green bars) ). We also found occasional clones comprised of a mixture of GS + and GS − cells (Fig. 3g , h (blue bars)). The 'cross-zone' clones derive from TERT High hepatocytes but comprise cells with two distinct zonal fates. These clonal studies matched the findings on homeostatic expansion of the TERT High lineage (Fig. 2) , and further supported the idea that TERT High hepatocytes are a key source of hepatocyte renewal.
TERT High hepatocytes could generate clones either by a self-renewal and differentiation mechanism, in which daughter cells are comprised Letter reSeArCH of both TERT High and TERT Low cells (Fig. 3j ), or by a simple duplication mechanism, in which all daughter cells remain TERT High (Fig. 3k ). To distinguish between these possibilities, we examined Tert mRNA with single-molecule RNA fluorescence in situ hybridization (FISH) on sorted Tomato + and Tomato − hepatocytes from different tracing periods (Fig. 3i, l-r Fig. 8c-f) . Although TERT High hepatocytes are rare within the GS + pericentral zone, there was a marked increase in the number of GS + Tomato + cells 7 days after injury (Fig. 4a-f ). These data indicate that injury to pericentral hepatocytes activates nearby TERT High hepatocytes, and that their progeny assume a new zonal identity in healing pericentral wounds. To understand whether TERT High hepatocytes contribute to hepatocyte regeneration after global injury, we challenged the livers with a 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet ( Fig. 4g and Extended Data Fig. 8g, h ). There was a significant expansion of Tomato + hepatocytes after 1 month of the DDC diet (38.0 ± 3.2% versus 5.6 ± 0.3% in control livers, P = 0.0018; Fig. 4g-j) . Some progeny of TERT High cells adopted a ductal fate (Extended Data Fig. 9 ), consistent with known hepatocyte plasticity following DDC-induced injury 26 . These findings reveal that TERT High hepatocytes repopulate hepatocytes at an accelerated rate in the setting of chemical injury.
To determine whether TERT High hepatocytes are required for normal injury responses, we ablated Tert-expressing hepatocytes using a diphtheria toxin (DTA)-based AAV system, in which hepatocytespecific expression of DTA is induced upon Cre-mediated deletion of a loxP-EGFP-Stop-loxP element (Fig. 4k-m) . Intravenous infection of wild-type mice with both AAV-lsl-DTA and AAV-Cre resulted in massive hepatocyte necrosis and death within 6 days, whereas infection with AAV-lsl-DTA alone was well tolerated for up to 2 months and did not induce liver damage (Extended Data Fig. 10f-j ) cells was reduced by 75.1% in mice treated with AAV-lsl-DTA compared with those treated with AAV-GFP (Fig. 4m) . After ablating TERT High cells, we induced liver injury with a DDC diet for 30 days (Fig. 4n) . Expansion of the TERT High (Tomato + ) cell lineage was substantially suppressed in mice treated with AAV-lsl-DTA (Fig. 4s, v) compared with those treated with AAV-GFP (Fig. 4r, u) . DDC treatment following ablation of TERT High hepatocytes led to a marked increase in liver fibrosis, shown by an increase in collagen deposition ( Fig. 4o-q) and a concomitant increase in the number of activated stellate cells (Fig. 4r-t) . There was an associated increase in cells positive for the ductal marker CK19 (Fig. 4u-w) , indicating that suppression of hepatocyte renewal enhances the ductal reaction characteristic of DDC treatment. Finally, we replicated these results using an independently constructed AAV that allows induction of DTA through Cre-mediated inversion and deletion steps (AAV-flex-DTA) (Extended Data Fig. 10) . Together, these data show that TERT High hepatocytes are critical for normal liver regeneration in the setting of DDC injury and that regeneration in their absence results in elevated stellate cell activation and fibrosis.
On the basis of the dispersed location of TERT High hepatocytes and their clonal behaviour during regeneration, we propose a 'distributed model' to explain hepatocyte renewal. According to this model, rare 
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TERT
High hepatocytes located throughout the lobule form enlarging clones during homeostasis in response to hepatocyte loss, and this response is accelerated during liver injury (Fig. 5) . These findings provide a framework that can explain several longstanding observations in hepatocyte renewal, including the ability of the liver to recover from injuries in any lobular zone; a general lack of evidence for long-range migration of hepatocytes; and the presence of rare proliferating hepatocytes throughout the lobule. Our RNA-seq data suggest that repopulating activity and metabolism may be segregated within the hepatocyte population. Telomerase activity is critical for preserving long-term cell division and chromosomal stability. Maintaining the liver using a subset of hepatocytes with elevated telomerase and reduced metabolic activity may be important for long-term tissue maintenance, for preventing the accrual of damaged DNA caused by reactive oxygen species and for suppressing hepatocellular carcinoma. We speculate that depletion or dysfunction of an analogous subset of repopulating hepatocytes in humans may underlie the pathophysiology of cirrhosis. Strategies to mitigate this cellular depletion may prove useful in treating cirrhosis of diverse aetiologies.
Online content
Any Methods, including any statements of data availability and Nature Research reporting summaries, along with any additional references and Source Data files, are available in the online version of the paper at https://doi.org/10.1038/s41586-018-0004-7. CreERT2/+ clone was targeted with a modified Rosa26-mTmG targeting vector 29 using HygroR as the selection gene. The double knock-in cells were treated with 500 nM 4-hydroxy tamoxifen (4-OHT) to evaluate recombination efficiency. AAV production. All AAVs used in this study were produced with cis-plasmids containing the full TBG promoter (two copies of the α-1-microglobulin/bikunin precursor (AMBP) enhancer elements followed by the promoter of the SERPINA7 gene and a mini-intron), an AAV8 serotype packaging plasmid, and an adenovirus helper plasmid. AAV-GFP (AAV8-TBG-PI-eGFP-WPRE-bGH, catalogue no. AV-8-PV0146) and AAV-Cre (AAV8-TBG-PI-Cre-rBG, catalogue no. AV-8-PV1091) were purchased from the University of Pennsylvania Vector Core. AAV-lsl-DTA contains a strong SV40 stop element cloned from the Lox-StopLox TOPO plasmid 30 (addgene Plasmid no. 11584). AAV-flex-DTA was modified from pAAV-mCherry-flex-DTA 31 (addgene Plasmid no. 58536) with the following changes: the EF-1α promoter was swapped with the TBG promoter, and mCherry was swapped with EGFP. HEK293T cells were transfected and grown on Corning multi-layer flasks to produce the viruses. The viruses were purified by Iodixanol (Sigma-Aldrich) gradient ultracentrifugation 32 , and titred by qPCR 33 and SYPRO Ruby (ThermoFisher) protein gel staining with standards.
Animals. Tert
CreERT2/+ mice were bred with the Rosa26 reporter (Gt(ROSA)26Sor tm14(CAG-tdTomato)Hze/J) line 34 
to generate Tert
CreERT2/+
Rosa26
LSL-Tomato/+ mice for analysis. Two-month-old mice were intraperitoneally injected with tamoxifen (Caymon, 1 mg per 10 g weight) dissolved in 100 µl sesame oil (Sigma-Aldrich). Sparse labelling was achieved by injecting tamoxifen at 0.08 mg per 10 g weight. EdU (Carbosynth) was administrated via drinking water (1 mg/ml) daily for seven days. AAV was diluted to 4 × 10 11 genome particles in 100 µl normal saline (per mouse), and injected intravenously. For DDC injury, mice received diet TD.07571 (Harlan) containing 0.1% DDC (Sigma-Aldrich) ad libitum. For CCl 4 injury, mice were injected with liquid CCl 4 (Sigma-Aldrich, 10 µl per 10 g weight) dissolved in sesame oil (Sigma-Aldrich). Statistics. No statistical methods were used to predetermine sample sizes. When comparing two groups, P values were determined by two-sided unpaired t-test. When comparing more than two groups, P values were determined by one-way ANOVA with Tukey's HSD test performed as the post hoc analysis. Data significance was also tested by non-parametric statistics using two-sided unpaired Wilcoxon-Mann-Whitney test for two-group comparison, and Kruskal-Wallis one-way ANOVA on ranks with Conover-Iman test performed as the post hoc analysis for more than two groups. Kolmogorov-Smirnov test was performed to compare the distribution patterns of continuous variables. The animals were randomly assigned to each experimental or control group. The investigators were not blinded to allocation during experiments and outcome assessment. Data are presented as mean ± s.e.m. Graphs were generated by the ggplot2 package 35 in R. FACS experiments. Cells were isolated by standard two-step collagenase perfusion. Liver perfusion medium (Life Technologies) and filtered (0.22 µm) liver digest medium (Life Technologies) were perfused via the portal vein sequentially, according to the manufacturer's instructions. Dissociated liver was passed through a 100-µm cell strainer and the hepatocytes were enriched by low-speed centrifugation (50g for 3 min) three times in hepatocyte wash medium (Life Technologies). Cells were analysed and/or sorted with a BD Aria II flow cytometer using a 100-µm nozzle. Dead cells were excluded by Topro3 (1 µM) or DAPI (1 µM) (Life Technologies) incorporation. For ploidy analysis, hepatocytes were incubated in Hoechst 33342 (15 µg/ml) and Reserpine (5 µM) at 37 °C for 30 min before analysis. Immunofluorescence, imunohistochemistry, EdU detection, single-molecule RNA FISH and SiriusRed staining. Livers were cut into small blocks, and fixed in zinc-buffered formalin (Anatech). For immunofluorescence, tissue blocks were fixed overnight at 4 °C, cryoprotected in 30% (w/v) sucrose, embedded in OCT, snap-frozen and cut into 7-µm cryosections. For thick tissue analysis, tissue blocks were briefly fixed, embedded in low-melting agarose and cut into 300-µm sections using a vibratome, as previously described 36 . For immunohistochemistry, tissue blocks were fixed overnight at 4 °C, incubated in 70% ethanol overnight, embedded in paraffin and cut into 5-µm sections. Antigen retrieval was performed with citrate (pH 6) buffer (Biogenex) for 10 min using a pressure cooker. Slides were stained with primary and secondary antibodies in blocking buffer (1% BSA, 5% donkey serum, 0.25% Triton-X in PBS) overnight at 4 °C, incubated with 1 mM DAPI for 5 min at room temperature, and mounted in Aqua poly/mount (Polysciences), or Vectashield with DAPI (Vector laboratories). DAB Peroxidase Substrate Kit (Vector Laboratories) or Emerald chromogen kit (Abcam) were used for immunohistochemistry. EdU incorporation was detected by using the Click-iT EdU Alexa Fluor 488 Imaging Kit (Life Technologies). For analysis on cytospun samples, cells were FACS-sorted and cytospun (500 r.p.m./28g for 5 min) onto slides. Slides were fixed in 4% (v/v) PFA for 5 min, and stained with primary and secondary antibodies in blocking buffer for 1 h at room temperature, and then mounted in Prolong Gold with DAPI mounting medium (Life Technologies). Alternatively, slides were fixed in 4% (v/v) PFA for 20 min, and processed for single-molecule RNA FISH using an RNAscope 2.0 HD Detection-RED kit (ACDbio) according to the manufacturer's instructions. SiriusRed staining for collagen deposit was performed with Fast Green as the counter-stain, using a staining kit (Chondrex), according to the manufacturer's instructions. RT-qPCR and RNA-seq. RT Imaging analysis. Fluorescent images were analysed using Leica LAS AF, ImageJ, Adobe Photoshop and Fluorender. Area index was defined by the liver area covered by Tomato + cells as the percentage of total area, and quantified by ImageJ. 3D reconstruction was performed using Fluorender. Multicellular clones were imaged in 258 × 258 × 100-µm 3 volumes using a Leica SP8 confocal microscope or a Prairie Ultima IV two-photon microscope. Clones composed of more than eight cells often extended the imaging volume, and therefore were counted as eight cells. The surface planar view was created by maximum-projection of the first 12-µm volume close to the surface to approximate staining results from thin sections. For co-immunostaining with GS, 580 × 580 × 100-µm 3 volumes were imaged. Stitched single-plane images were processed from individual tiles by Adobe Photoshop. The number of EdU
+ hepatocytes was manually counted. TRAP assays. Telomeric repeat amplification protocol (TRAP) was carried out by a previously established protocol 40 . FACS-sorted cells or homogenized tissue were lysed in NP40 buffer (25 mM HEPES-KOH, 400 mM NaCl, 1.5 mM MgCl 2 , 10% glycerol, 0.5% NP40, and 1 mM DTT (pH 7.5) supplemented with protease inhibitors). Ethical compliance. All animal protocols were approved by the Institutional Animal Care and Use Committee at Stanford University. All experiments complied with the relevant ethical regulations of Stanford University. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper. Code availability. Codes are available from the corresponding author upon request. Data availability. The source data for the RNA-seq study are available in the NCBI Gene Expression Omnibus (GEO) repository under accession number GSE104415. Source Data for Figs. 1-5 and Extended Data Fig. 1-7, 9 , 10 are available with the online version of the paper. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined. Sample sizes were set using power calculation, based on effect size, significant level and power level.
Data exclusions
Describe any data exclusions.
No individual samples or animals were excluded from any analyses.
Replication
Describe whether the experimental findings were reliably reproduced.
All replication experiments were statistically analyzed and presented in the paper.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The animal were randomly assigned to each experimental/control group.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The investigators were not blinded to the identities of the samples. All experimental and corresponding control samples were collected and analyzed at the same time under the same condition. Quantification was made with the same software settings.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
